BioXcel Therapeutics Market Cap 2017-2024 | BTAI

BioXcel Therapeutics market cap as of January 29, 2025 is $0.02B.

BioXcel Therapeutics market cap history and chart from 2017 to 2024. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding.

BioXcel Therapeutics Market Cap 2017-2024 | BTAI

BioXcel Therapeutics market cap history and chart from 2017 to 2024. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding.
Related Stocks
Company NameMarket
Cap
Amgen (AMGN)$147B
Gilead Sciences (GILD)$116B
Bristol Myers Squibb (BMY)$115.8B
Vertex Pharmaceuticals (VRTX)$110.2B
CSL (CSLLY)$81.9B
Regeneron Pharmaceuticals (REGN)$74.7B
GSK (GSK)$69.3B
Argenex SE (ARGX)$38.6B
Alnylam Pharmaceuticals (ALNY)$34.4B
BioNTech SE (BNTX)$27.6B
Illumina (ILMN)$22.3B
BeiGene (ONC)$21.7B
Biogen (BIIB)$20.8B
Moderna (MRNA)$14.8B
Insmed (INSM)$14B
Incyte (INCY)$13.9B
Genmab (GMAB)$13.9B
Genmab (GNMSF)$13.9B
Intra-Cellular Therapies (ITCI)$13.5B
Bio-Techne Corp (TECH)$12.5B
BioMarin Pharmaceutical (BMRN)$11.8B
Sarepta Therapeutics (SRPT)$11.1B
Vaxcyte (PCVX)$10.8B
QIAGEN (QGEN)$10.8B
Exact Sciences (EXAS)$10.1B
Swedish Orphan Biovitrum (BIOVF)$10.1B
Bio-Rad Laboratories (BIO.B)$9.8B
Exelixis (EXEL)$9.4B
Repligen (RGEN)$9.3B
Roivant Sciences (ROIV)$8.1B